SCHEMBL5105611

SCHEMBL5105611

O=Cc1ccc2[nH]cnc(=O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.45
▸ CYP2A6 P11509 4/20 0.43
▸ IP6K1 Q92551 5/20 0.38
▸ IP6K3 Q96PC2 2/20 0.38
▸ IP6K2 Q9UHH9 1/20 0.38
▸ P2RY14 Q15391 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ PRNP P04156 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4604806 0.85 TYMS (0.38) KIF11IP6K1IP6K3IP6K2ALDH1A1
SCHEMBL1584889 0.77 PIM1 (0.56) CYP2A6ALDH1A1CYP1A2MEN1PRNP
SCHEMBL29505633 0.77 CYP2A6 (0.47) KIF11CYP2A6IP6K1IP6K3IP6K2
SCHEMBL1160196 0.77 CYP2A6 (0.47) KIF11CYP2A6IP6K1IP6K3IP6K2
SCHEMBL8622177 0.77 ACVR1 (0.46) IP6K1ALDH1A1MEN1PRNPMAPT
SCHEMBL216175 0.75 PARP1 (0.54) ALDH1A1MEN1PRNPMAPTHPGD
SCHEMBL2191063 0.75 PARP1 (0.54) ALDH1A1CYP2C19HTTKMT2ACHEK1
SCHEMBL1507612 0.75 PARP1 (0.54) ALDH1A1MEN1HPGDKMT2ASMN1; SMN2
SCHEMBL2574527 0.75 LMNA (0.57) ALDH1A1CYP1A2MEN1MAPTHPGD
SCHEMBL2191001 0.75 PARP1 (0.54) ALDH1A1CYP1A2HPGDCHEK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080261974-A1 Novel Chemical Compounds DUFFY KEVIN J 2008-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080261974-A1 Novel Chemical Compounds HIPK3, HIPK1, HIPK4 KIF11 808/4885CYP2A6 4760/4885IP6K1 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback